Timothy Barabe, Director at Arqule, holds 21.77K shares in Cartesian Therapeutics (Ticker: RNAC), holds 6.64K shares in Veeva Systems (Ticker: VEEV), holds 0.00 shares in Arqule (Ticker: ARQL). Most recently, Timothy Barabe Bought ― shares of Cartesian Therapeutics on Aug 14, 2024 for an estimated value of 95.25K.
Timothy Barabe latest transaction was an Informative Buy of $95.25K.
What was Timothy Barabe's most profitable transaction?
Timothy Barabe’s most profitable transaction was an Informative Buy of RNAC stock on March 19, 2020. The return on the trade was 170.70%.
What is Timothy Barabe's role in Arqule?
Timothy Barabe's role in Arqule is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.